Environment
Mixed / Neutral
50%
Benefits
- No direct sector effect identified
Risks
- No direct sector effect identified
StateMassachusettsIntroduced
HD 5873: A communication from the Executive Office of Health and Human Services (see Section 80 of Chapter 118E of the General Laws) submitting its report on the needs of MassHealth enrollees with a diagnosis of sickle cell disease and the adequacy of available covered medications, treatments and health care services
Executive Office of Health and Human Services
HD 5873 status: Introduced — Placed on file (updated Aug 17, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
75OUT OF 100
Score:75/100 civic fit
Risk:Low Risk
Impact:Low Impact 20/100
Earlier scoring method. Reanalyze to use the sector calculation.
Constitutionality100%
Bipartisan50%
Public opinion60%
Bill summary
A communication from the Executive Office of Health and Human Services (see Section 80 of Chapter 118E of the General Laws) submitting its report on the needs of MassHealth enrollees with a diagnosis of sickle cell disease and the adequacy of available covered medications, treatments and health care services. Currently in House.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
50%
Benefits
- Supports data-driven healthcare fiscal planning
Risks
- No direct economic impact identified
Society
Positive outlook
75%
Benefits
- Increases transparency regarding sickle cell patient needs
- Supports identification of healthcare coverage gaps
Risks
- Report submission does not guarantee new funding or policy changes
Technology Industry
Not scored in this analysis.
Generate analysis again to evaluate this sector.
Civic Accountability
Not scored in this analysis.
Generate analysis again to evaluate this sector.
Public Health & Safety
Not scored in this analysis.
Generate analysis again to evaluate this sector.
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
The submission of this report does not constitute the enactment of new programs or resource allocation for sickle cell treatment
Analysis scope
Full bill text is not available
04
Where it stands
Official record- IntroducedCurrent
- CommitteeUpcoming
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.